3DKnee™ System vs. the MJS Knee System

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

27 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-01-31

Study Completion Date

2009-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to compare the survivorship and efficacy of the Encore 3DKnee™ system with that of the Encore MJS™ Knee System in a group of 600 patients for whom data collection is already under way.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The 3DKnee™ System: A Post-Market Study

NCT00764673

Osteoarthritis Rheumatoid Arthritis Post Traumatic Arthritis +2 more

COMPLETED PHASE4

Post-Market Study of the EPIK Knee System

NCT01464632

Osteoarthritis Post Traumatic Degenerative Disease

WITHDRAWN

Post Market Study of the 3DKnee™ With E-plus Insert

NCT01551472

Degenerative Joint Disease Osteoarthritis Traumatic Arthritis

TERMINATED

Post-Market Study of the 3DKnee™ System

NCT00819481

Degenerative Joint Disease Osteoarthritis Rheumatoid Arthritis +1 more

COMPLETED

Foundation Knee Study - Retrospective

NCT00764894

Osteoarthritis Post-traumatic Arthritis Inflammatory Tissue Disorders +2 more

TERMINATED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The purpose of this study is to compare the survivorship and efficacy of the Encore 3DKnee™ system with that of the Encore MJS™ Knee System in a group of 600 patients for whom data collection is already under way. Approximately 300 patients have already received the MJS™ knee system and data, as described below, has been collected for these patients over a period of two years. A second group of 300 patients will receive the Encore 3DKnee™ system over the next two years, and equivalent data will be collected for these individuals. A portion of the data has been collected over the past year, and now we would like to obtain permission from the patients to analyze these data as well as collect an additional year of data.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Rheumatoid Arthritis Traumatic Arthritis Joint Disease Secondary to Osteoarthritis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

2

Subjects who meet the indications for use and are implanted with the Encore MJS™ Knee System.

Encore MJS™ Knee System

Intervention Type DEVICE

Subjects with rheumatoid arthritis, traumatic arthritis or osteoarthritis who were implanted with the Encore MJS™ Knee system and willing to participate in the study.

1

Subjects who meet the indications for and are implanted with the Encore 3DKnee™ system.

Encore 3DKnee™ system

Intervention Type DEVICE

Subjects with rheumatoid arthritis, traumatic arthritis or osteoarthritis who were implanted with the Encore 3DKnee™ system and willing to participate in the study.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Encore 3DKnee™ system

Subjects with rheumatoid arthritis, traumatic arthritis or osteoarthritis who were implanted with the Encore 3DKnee™ system and willing to participate in the study.

Intervention Type DEVICE

Encore MJS™ Knee System

Subjects with rheumatoid arthritis, traumatic arthritis or osteoarthritis who were implanted with the Encore MJS™ Knee system and willing to participate in the study.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* This must be a primary knee replacement on this knee.
* Patient is over 18 years of age or older
* Patients must have one of the following

* rheumatoid or traumatic arthritis OR
* joint disease secondary to osteoarthritis
* Patient is likely to be available for evaluation for the duration of the study
* Able and willing to sign the informed consent and follow study procedures
* Patient is not pregnant

Exclusion Criteria

* Is younger than 18 years of age
* If there has been a total knee replacement on this knee in the past (no revisions allowed in study)
* Overt infection
* Alcoholism or other addictions
* Muscular, neurological or vascular deficiencies which compromise the affected extremity
* Obesity
* Marked bone loss
* Materials sensitivity
* Prisoner
* Mental conditions that may interfere with the patient's ability to give an informed consent or willingness to fulfill the study requirements
* Patient is pregnant

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No